CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 15 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $30,360 | +13.0% | 26,867 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $26,864 | +15.2% | 26,867 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $23,315 | -33.4% | 26,867 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $35,000 | -48.5% | 26,867 | -65.5% | 0.00% | -50.0% |
| Q2 2022 | $68,000 | -71.1% | 77,851 | 0.0% | 0.00% | -60.0% |
| Q1 2022 | $235,000 | +53.6% | 77,851 | +162.3% | 0.01% | +25.0% |
| Q4 2021 | $153,000 | – | 29,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,991,003 | $36,004,000 | 0.64% |
| Octagon Capital Advisors LP | 279,921 | $1,442,000 | 0.28% |
| Altium Capital Management LP | 175,000 | $901,000 | 0.25% |
| Deep Track Capital, LP | 647,057 | $3,332,000 | 0.24% |
| Ikarian Capital, LLC | 262,237 | $1,350,000 | 0.20% |
| Cormorant Asset Management, LP | 200,000 | $1,030,000 | 0.06% |
| DLD Asset Management, LP | 121,707 | $627,000 | 0.03% |
| RTW INVESTMENTS, LP | 450,000 | $2,318,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,250,000 | $6,438,000 | 0.01% |
| Chicago Partners Investment Group LLC | 21,892 | $97,000 | 0.01% |